Recent VAXX News
- Vaxxinity Issues Shareholder Letter • GlobeNewswire Inc. • 04/19/2024 10:53:35 PM
- Vaxxinity Announces Intention to Voluntarily Delist and Deregister its Class A Common Stock • GlobeNewswire Inc. • 04/19/2024 08:27:16 PM
- Vaxxinity to Present Clinical Data at the Annual Academy of Neurology 2024 Annual Meeting • GlobeNewswire Inc. • 03/28/2024 01:23:21 PM
- Vaxxinity Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Corporate Updates • GlobeNewswire Inc. • 03/27/2024 08:41:12 PM
- Vaxxinity Announces Positive Target Engagement Data from Phase 1 Clinical Trial for Parkinson’s Disease at AD/PD™ 2024 • GlobeNewswire Inc. • 03/07/2024 03:32:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 09:15:34 PM
- Vaxxinity’s Cholesterol Vaccine Candidate Successfully Lowers LDL-C: Preclinical Data Published • GlobeNewswire Inc. • 02/15/2024 01:00:14 PM
- Vaxxinity to Present Clinical and Preclinical Pipeline Data at AD/PD 2024 • GlobeNewswire Inc. • 02/13/2024 01:00:53 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/12/2024 10:02:04 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/12/2024 10:02:01 PM
- Vaxxinity Announces Research Collaboration on Active Immunotherapies for Neurodegenerative Diseases with University of Florida • GlobeNewswire Inc. • 01/30/2024 01:00:56 PM
- Vaxxinity Announces Collaboration on Space Medicine Research with University of Central Florida • GlobeNewswire Inc. • 01/18/2024 01:00:58 PM
- Vaxxinity to Present at the 2024 J.P. Morgan Healthcare Conference • GlobeNewswire Inc. • 01/03/2024 01:00:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/01/2023 03:30:29 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/30/2023 10:03:06 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/30/2023 09:54:33 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/29/2023 10:13:26 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/29/2023 10:10:31 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/21/2023 09:21:56 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/21/2023 09:20:06 PM
- Vaxxinity to Present at Upcoming November Medical and Investor Conferences • GlobeNewswire Inc. • 11/13/2023 11:50:00 PM
- Vaxxinity Reports Third Quarter 2023 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 11/08/2023 01:30:11 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/08/2023 12:53:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/03/2023 08:31:37 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 10/04/2023 08:33:44 PM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM
Avant Technologies Launches Advanced AI Supercomputing Network and Expansive Data Solutions • AVAI • Apr 23, 2024 8:00 AM
BestGrowthStocks.com Issues Comprehensive Analysis of Triller Merger with AGBA Group Holding Limited • AGBA • Apr 22, 2024 1:00 PM
Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California • BLO • Apr 22, 2024 8:49 AM